Unlocking the Mysteries of N-oxPTH: Implications for CKD Patients

Overview

Journal Front Endocrinol (Lausanne)

Date 2025 Jan 20

PMID 39829956

Authors

Lina Zhang

Huixia Cao

Affiliations

Soon will be listed here.

Abstract

Parathyroid hormone (PTH) is a pivotal hormone that regulates serum calcium and phosphate and is closely associated with higher risk of cardiovascular disease and mortality in patients with chronic kidney disease (CKD). PTH can undergo oxidation at methionine 8 and methionine 18 of the molecule. This oxidation process leads to a lower binding affinity to the PTH receptor due to molecular refolding, particularly for PTH oxidized at methionine 8. Although, the oxidation of PTH has been reported for several decades, it is only recently that a method has been developed to detect non-oxidized PTH (n-oxPTH) levels. The utilization of this assay enables the precise detection of n-oxPTH levels and facilitates the evaluation of their correlation with poor prognosis in patients with CKD. However, the current available clinical research findings indicate that n-oxPTH does not demonstrate clinical superiority over iPTH. Here, we provide a comprehensive review on the mechanism of PTH oxidation, the n-oxPTH assay method, and its correlation with iPTH and clinical outcomes.

References

Kritmetapak K, Losbanos L, Hines J, OGrady K, Ulmer C, Vesper H . Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure. Clin Chem. 2021; 67(6):843-853. PMC: 8167341. DOI: 10.1093/clinchem/hvab013. View

Chu L, Forte L, Anast C, Cohn D . Interaction of parathyroid hormone with membranes of kidney cortex: degradation of the hormone and activation of adenylate cyclase. Endocrinology. 1975; 97(4):1014-23. DOI: 10.1210/endo-97-4-1014. View

Lu Y, Zeng S, Chu C, Hasan A, Slowinski T, Yin L . Non-oxidized PTH (n-oxPTH) is associated with graft loss in kidney transplant recipients. Clin Chim Acta. 2020; 508:92-97. DOI: 10.1016/j.cca.2020.05.022. View

Russell J, Lettieri D, Sherwood L . Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology. 1986; 119(6):2864-6. DOI: 10.1210/endo-119-6-2864. View

ORIORDAN J, Woodhead J, Hendy G, Parsons J, Robinson C, Keutmann H . Effect of oxidation on biological and immunological activity of porcine parathyroid hormone. J Endocrinol. 1974; 63(1):117-24. DOI: 10.1677/joe.0.0630117. View

Soliman M, Hassan W, Yaseen M, Rao M, Sawaya B, El-Husseini A . PTH assays in dialysis patients: Practical considerations. Semin Dial. 2018; 32(1):9-14. DOI: 10.1111/sdi.12743. View

Demay M, Mitchell J, Goltzman D . Comparison of renal and osseous binding of parathyroid hormone and hormonal fragments. Am J Physiol. 1985; 249(5 Pt 1):E437-46. DOI: 10.1152/ajpendo.1985.249.5.E437. View

Laethem R, Zull J . Characterization of the interaction of parathyroid hormone with the mitochondrial ATPase. Arch Biochem Biophys. 1990; 282(1):161-9. DOI: 10.1016/0003-9861(90)90100-d. View

Tepel M, Armbruster F, Gron H, Scholze A, Reichetzeder C, Roth H . Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients. J Clin Endocrinol Metab. 2013; 98(12):4744-51. DOI: 10.1210/jc.2013-2139. View

10.

Klaus G, May T, Hugel U, von Eichel B, Rodriguez J, Fernandez P . Parathyroid hormone prevents 1,25 (OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro. Kidney Int. 1997; 52(1):45-51. DOI: 10.1038/ki.1997.302. View

11.

Kilav R, Silver J, Naveh-Many T . A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J Biol Chem. 2000; 276(12):8727-33. DOI: 10.1074/jbc.M005471200. View

12.

Zuo J, Hasan A, Hocher C, Kalk P, Kleuser B, Kramer B . Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients. Front Endocrinol (Lausanne). 2023; 14:1178166. PMC: 10264784. DOI: 10.3389/fendo.2023.1178166. View

13.

Horiuchi N . Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized rats. J Bone Miner Res. 1988; 3(3):353-8. DOI: 10.1002/jbmr.5650030316. View

14.

Evenepoel P, Bover J, Urena Torres P . Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 2016; 90(6):1184-1190. DOI: 10.1016/j.kint.2016.06.041. View

15.

Frelinger 3rd A, Zull J . Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18. J Biol Chem. 1984; 259(9):5507-13. View

16.

Sham J, KENNY A, Pang P . Cardiac actions and structural--activity relationship of parathyroid hormone on isolated frog atrium. Gen Comp Endocrinol. 1984; 55(3):373-7. DOI: 10.1016/0016-6480(84)90006-6. View

17.

Bieglmayer C, Kaczirek K, Prager G, Niederle B . Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem. 2006; 52(6):1112-9. DOI: 10.1373/clinchem.2005.065490. View

18.

Almond A, Ellis A, Walker S . Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem. 2011; 49(Pt 1):63-7. DOI: 10.1258/acb.2011.011094. View

19.

Lee S, Lee M, Ryu G, Jhee J, Kim H, Park S . Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int. 2016; 27(9):2717-2726. DOI: 10.1007/s00198-016-3636-1. View

20.

DAmour P, Palardy J, Bahsali G, Mallette L, Delean A, LePage R . The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab. 1992; 74(3):525-32. DOI: 10.1210/jcem.74.3.1740486. View